Kaiser Permanente Ventures

Kaiser Permanente is a nonprofit healthcare organization that provides a comprehensive range of services, including preventive care, emergency care, hospital and medical services, as well as pharmacy services. Founded in 1945 and headquartered in Oakland, California, Kaiser Permanente has a strong presence in several states, including California, Colorado, Georgia, Hawaii, Ohio, Oregon, Washington, and the District of Columbia. The organization operates through a model that emphasizes integrated care, focusing on the overall health and well-being of its members. Additionally, Kaiser Permanente Ventures, established in 1997, serves as the venture capital arm of the organization, investing in innovative healthcare companies. The firm primarily targets investments in healthcare services, medical devices, diagnostics, health information technology, and biotechnology, focusing on companies based in the United States with substantial market potential. Through these initiatives, Kaiser Permanente aims to influence the future of healthcare delivery while supporting advancements within the industry.

Greg A. Adams

Chairman and CEO

Amy Belt Raimundo

Vice President and Managing Director

Sam Brasch

Senior Managing Director; KP Venture

Chris Grant

COO and Executive Vice President

Yvette Radford

Vice President

Liz Rockett

Managing Director

Jian Yu

Associate Chief Actuary

Past deals in Health Care

Incredible Health

Series B in 2022
Incredible Health, Inc. is a San Francisco-based company that offers an online recruitment platform designed to assist healthcare providers in hiring full-time clinical staff efficiently. The platform enables hospitals and health systems to find high-quality clinicians in less than 30 days, streamlining the staffing process. Unlike traditional job searches, candidates do not apply to employers; instead, employers seek out candidates through an intuitive web application. Incredible Health also provides a mobile application that enhances the user experience. The company, originally known as Lift League, Inc., was incorporated in 2015 and has since focused on solving staffing challenges within the healthcare industry by allowing users to filter job searches, receive alerts, and access career advice.

IntelyCare

Series C in 2022
IntelyCare, Inc. provides on-demand staffing services tailored for healthcare organizations, focusing primarily on post-acute care facilities. Established in 2014 and headquartered in Quincy, Massachusetts, the company offers a digital workforce augmentation platform that combines a gig-model application with advanced data science. This platform allows healthcare facilities to optimize staffing levels by efficiently matching nursing professionals with available shifts, thereby addressing the growing gap between workforce supply and demand. Nurses and nursing assistants benefit from the platform by having the flexibility to create their own schedules and select shifts that suit them, promoting a more engaged and productive workforce. IntelyCare serves a variety of clients, including home care agencies, assisted living facilities, long-term care facilities, and rehabilitation hospitals. As a subsidiary of Leerink Revelation Healthcare Fund II GP, LLC, IntelyCare is positioned to revolutionize the healthcare staffing market by filling nursing shifts at a rate three times higher than the industry average.

Big Health

Series C in 2022
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

DexCare

Series B in 2022
DexCare is a provider of Platform-as-a-Service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

Medically Home

Venture Round in 2022
Medically Home Group, Inc., based in Boston, Massachusetts, offers a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on providing patient-centered care for individuals with serious or complex illnesses, including conditions such as heart failure, pneumonia, urinary tract infections, cellulitis, and respiratory issues. Medically Home's innovative model enables the safe transition of medical care from traditional hospital settings to patients' homes, allowing for centralized, on-demand management of acute medical needs. This approach connects patients with caregivers while facilitating monitoring and communication, ensuring that patients and their families receive comprehensive support in a familiar environment.

Genome Medical

Series C in 2021
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

OM1

Series D in 2021
OM1, Inc. is a digital health company that develops a platform aimed at measuring and forecasting patient outcomes data for healthcare organizations. The platform supports hospitals and health systems in meeting requirements for patient-reported and clinical outcomes, particularly in value-based care programs and bundle payments. By leveraging advanced analytics, the platform provides predictive and prescriptive insights that help mitigate risks and reduce costs while demonstrating outcomes to various stakeholders. OM1's technology synthesizes and enriches clinical data to offer AI-driven insights that enhance clinical, financial, and operational management, thereby establishing a new standard for health outcomes information. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Protenus

Series D in 2021
Protenus, Inc. is a Baltimore-based company that specializes in a healthcare compliance analytics platform designed to protect patient privacy and secure health data. Utilizing artificial intelligence, the platform audits every access to patient records across leading health systems in the United States. It enables healthcare organizations to gain comprehensive insights into the usage of health data, proactively identifying risks such as inappropriate access to patient information and potential theft or misuse of controlled substances by staff. By alerting compliance teams to policy violations and other anomalous behaviors, Protenus empowers hospitals to make informed decisions to enhance data protection and safeguard their institutions. The company, which was established in 2014 and previously known as Protenus, LLC, focuses on reducing risk and optimizing operational efficiency for its partner hospitals.

Medically Home

Corporate Round in 2021
Medically Home Group, Inc., based in Boston, Massachusetts, offers a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on providing patient-centered care for individuals with serious or complex illnesses, including conditions such as heart failure, pneumonia, urinary tract infections, cellulitis, and respiratory issues. Medically Home's innovative model enables the safe transition of medical care from traditional hospital settings to patients' homes, allowing for centralized, on-demand management of acute medical needs. This approach connects patients with caregivers while facilitating monitoring and communication, ensuring that patients and their families receive comprehensive support in a familiar environment.

Groups Recover Together

Series C in 2021
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

Vesta Healthcare

Venture Round in 2021
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Evidation Health

Series E in 2021
Evidation Health develops a health data analytics platform that collects and analyzes continuous behavior data alongside healthcare information to enhance health outcomes. Founded in 2012 and headquartered in San Mateo, California, the company utilizes raw, high-frequency data from various sources such as sensors, devices, and video to generate insights into health and disease. Its products include a Data Platform, which transforms everyday behavior data into actionable health measures, and Studies, a service for conducting real-world research that incorporates behavioral data to support clinical and commercial teams. Evidation Health connects digital health companies with healthcare providers and payers, facilitating a better understanding of how everyday behaviors influence health. The company's offerings also encompass health outcomes research, technology assessment, and predictive analytics services.

DexCare

Series A in 2021
DexCare is a provider of Platform-as-a-Service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

K Health

Series E in 2021
K Health, Inc. is a digital health company that offers a mobile application designed to provide personalized, data-driven health information and remote treatment options for a variety of conditions, including back and neck pain, allergies, and chronic illnesses. Founded in 2016 and headquartered in New York with an additional office in Israel, K Health leverages advanced machine learning techniques to analyze clinical health data, enabling users to better manage their health. The platform allows patients to understand how doctors diagnose and treat similar symptoms, facilitating access to quality care at a lower cost. Users can chat with healthcare professionals for less than traditional copays and maintain a history of their medical records, thereby empowering them with insights into their health management. K Health is supported by various prominent investors, reflecting its innovative approach to digital primary care.

Ginger

Series D in 2020
Ginger.io, Inc. operates a behavioral analytics platform that transforms mobile data into health insights, specifically focusing on mental healthcare. The platform provides users with instant access to evidence-based behavioral health coaching, therapy, and psychiatry through a smartphone application. This on-demand service connects behavioral health coaches, therapists, and psychiatrists to deliver personalized care around the clock. Users can collect and analyze both passive mobile sensor data and active patient-reported outcomes, allowing for the identification of behavioral patterns and novel findings. Ginger serves a diverse clientele, including researchers, physicians, healthcare providers, and millions of individuals through partnerships with leading employers and health plans. Founded in 2010 and headquartered in San Francisco, California, Ginger is dedicated to enhancing mental health support.

Genome Medical

Series B in 2020
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

Cedar

Series C in 2020
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and is headquartered in New York, New York.

Big Health

Series B in 2020
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

IntelyCare

Series B in 2020
IntelyCare, Inc. provides on-demand staffing services tailored for healthcare organizations, focusing primarily on post-acute care facilities. Established in 2014 and headquartered in Quincy, Massachusetts, the company offers a digital workforce augmentation platform that combines a gig-model application with advanced data science. This platform allows healthcare facilities to optimize staffing levels by efficiently matching nursing professionals with available shifts, thereby addressing the growing gap between workforce supply and demand. Nurses and nursing assistants benefit from the platform by having the flexibility to create their own schedules and select shifts that suit them, promoting a more engaged and productive workforce. IntelyCare serves a variety of clients, including home care agencies, assisted living facilities, long-term care facilities, and rehabilitation hospitals. As a subsidiary of Leerink Revelation Healthcare Fund II GP, LLC, IntelyCare is positioned to revolutionize the healthcare staffing market by filling nursing shifts at a rate three times higher than the industry average.

Vesta Healthcare

Series A in 2020
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Ginger

Series C in 2019
Ginger.io, Inc. operates a behavioral analytics platform that transforms mobile data into health insights, specifically focusing on mental healthcare. The platform provides users with instant access to evidence-based behavioral health coaching, therapy, and psychiatry through a smartphone application. This on-demand service connects behavioral health coaches, therapists, and psychiatrists to deliver personalized care around the clock. Users can collect and analyze both passive mobile sensor data and active patient-reported outcomes, allowing for the identification of behavioral patterns and novel findings. Ginger serves a diverse clientele, including researchers, physicians, healthcare providers, and millions of individuals through partnerships with leading employers and health plans. Founded in 2010 and headquartered in San Francisco, California, Ginger is dedicated to enhancing mental health support.

Protenus

Series C in 2019
Protenus, Inc. is a Baltimore-based company that specializes in a healthcare compliance analytics platform designed to protect patient privacy and secure health data. Utilizing artificial intelligence, the platform audits every access to patient records across leading health systems in the United States. It enables healthcare organizations to gain comprehensive insights into the usage of health data, proactively identifying risks such as inappropriate access to patient information and potential theft or misuse of controlled substances by staff. By alerting compliance teams to policy violations and other anomalous behaviors, Protenus empowers hospitals to make informed decisions to enhance data protection and safeguard their institutions. The company, which was established in 2014 and previously known as Protenus, LLC, focuses on reducing risk and optimizing operational efficiency for its partner hospitals.

Omada

Series D in 2019
Omada Health, Inc. is a digital healthcare company that creates online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health helps employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the needs of participants, including services for diabetes prevention and management, hypertension, behavioral health, and musculoskeletal issues. By integrating professional health coaching, connected devices, real-time data, and personalized feedback, Omada Health strives to empower individuals to engage with their health and achieve sustainable lifestyle changes. It is recognized as the largest provider of the National Diabetes Prevention Program by the CDC.

Health Catalyst

Series F in 2019
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

Health Catalyst

Debt Financing in 2019
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

Vesta Healthcare

Series A in 2018
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Multisensor Diagnostics

Seed Round in 2018
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients.

CareAcademy

Seed Round in 2018
CareAcademy operates an online training platform tailored for senior home care agencies and caregivers. Founded in 2013 by Helen Adeosun, the company provides evidence-based classes that help direct care workers enhance their skills and improve the quality of care they deliver to older adults. The platform offers a variety of courses covering essential topics such as infection control, nutrition, dementia care, and fall prevention, enabling caregivers to meet licensure requirements across all 50 states. CareAcademy has certified over 40,000 caregivers nationwide, emphasizing the importance of high-touch coaching and exceptional customer service. The training programs not only equip caregivers with the necessary knowledge and skills but also offer peace of mind to employers, ensuring that their teams are well-prepared to support seniors in living independently and safely at home.

Protenus

Series B in 2018
Protenus, Inc. is a Baltimore-based company that specializes in a healthcare compliance analytics platform designed to protect patient privacy and secure health data. Utilizing artificial intelligence, the platform audits every access to patient records across leading health systems in the United States. It enables healthcare organizations to gain comprehensive insights into the usage of health data, proactively identifying risks such as inappropriate access to patient information and potential theft or misuse of controlled substances by staff. By alerting compliance teams to policy violations and other anomalous behaviors, Protenus empowers hospitals to make informed decisions to enhance data protection and safeguard their institutions. The company, which was established in 2014 and previously known as Protenus, LLC, focuses on reducing risk and optimizing operational efficiency for its partner hospitals.

Genome Medical

Series A in 2018
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

Collective Medical

Series A in 2017
Collective Medical Technologies, Inc. is a health care technology company that specializes in a real-time collaboration software platform designed to enhance patient care. Founded in 2005 and based in Cottonwood Heights, Utah, the platform connects a patient's entire care team, including hospitals, primary and secondary clinics, health plans, and community organizations, facilitating the sharing of vital information. Collective Medical's system-agnostic platform is utilized by a nationwide network of health plans and providers to identify at-risk patients and encourage actionable collaboration among care teams. The platform aims to improve patient outcomes by reducing unnecessary emergency department visits and hospital readmissions, utilizing real-time data, risk analytics, and shared care guidelines to inform provider decision-making. As of December 30, 2020, Collective Medical operates as a subsidiary of PointClickCare Corp.

Protenus

Series A in 2017
Protenus, Inc. is a Baltimore-based company that specializes in a healthcare compliance analytics platform designed to protect patient privacy and secure health data. Utilizing artificial intelligence, the platform audits every access to patient records across leading health systems in the United States. It enables healthcare organizations to gain comprehensive insights into the usage of health data, proactively identifying risks such as inappropriate access to patient information and potential theft or misuse of controlled substances by staff. By alerting compliance teams to policy violations and other anomalous behaviors, Protenus empowers hospitals to make informed decisions to enhance data protection and safeguard their institutions. The company, which was established in 2014 and previously known as Protenus, LLC, focuses on reducing risk and optimizing operational efficiency for its partner hospitals.

Big Health

Series B in 2016
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

CareGuardian

Series B in 2016
CareGuardian, founded in 2014, is dedicated to enhancing the visibility, recognition, and empowerment of caregivers, both professional and family. The company aims to deliver exceptional care and support for older adults by reimagining caregiver training and fostering connections among caregivers. CareGuardian recognizes the critical role that family caregivers play in ensuring the safety and well-being of older adults, and it extends its support to them as well. The organization operates in various regions, focusing on creating a network that promotes quality care and meaningful interactions for those involved in caregiving.

Group Health Cooperative

Acquisition in 2015
Group Health Cooperative is a member-governed, non-profit healthcare organization that coordinates care and coverage. The organization offers health plans for individuals and families; state and federal employees; and employers such as small and large groups including employer-sponsored group plans. It also provides various specialty care services at its medical centers in contracted hospitals; and healthcare, pharmacy, and drug formulary services. In addition, Group Health Cooperative conducts non-proprietary public-interest research on preventing, diagnosing, and treating major health problems in the areas of aging and geriatrics, health services and economics, alternative approaches to healing, healthy communities, behavior change, medication use and patient safety, biostatistics, mental health, cancer, obesity, cardiovascular health, preventive medicine, child and adolescent health, vaccines and infectious diseases, chronic illness management, women’s health, and health informatics. Group Health Cooperative was founded in January 1947 and is based in Seattle, Washington with administrative offices in Tukwila, Bellingham, Spokane, Tacoma, and Kennewick, Washington.

Validic

Series B in 2015
Validic, Inc. is a healthcare technology company that specializes in a cloud-based platform designed to collect and manage mobile health data from various Internet-enabled applications and devices. Founded in 2010 and headquartered in Durham, North Carolina, Validic provides solutions such as Validic Solution, which connects patient-recorded data from digital health applications and wearables to healthcare providers; Validic Connect, which offers access to less common clinical and consumer devices; and Validic Mobile, focused on data collection from digital health apps and in-home devices. The platform simplifies the management of personal health data, enabling wellness companies, healthcare providers, pharmaceuticals, and health plans to access and utilize this information effectively.

Health Catalyst

Series D in 2015
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

Ginger

Series B in 2014
Ginger.io, Inc. operates a behavioral analytics platform that transforms mobile data into health insights, specifically focusing on mental healthcare. The platform provides users with instant access to evidence-based behavioral health coaching, therapy, and psychiatry through a smartphone application. This on-demand service connects behavioral health coaches, therapists, and psychiatrists to deliver personalized care around the clock. Users can collect and analyze both passive mobile sensor data and active patient-reported outcomes, allowing for the identification of behavioral patterns and novel findings. Ginger serves a diverse clientele, including researchers, physicians, healthcare providers, and millions of individuals through partnerships with leading employers and health plans. Founded in 2010 and headquartered in San Francisco, California, Ginger is dedicated to enhancing mental health support.

Omada

Series B in 2014
Omada Health, Inc. is a digital healthcare company that creates online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, Omada Health helps employers and health plans identify individuals at risk for preventable chronic diseases such as prediabetes, diabetes, hypertension, and heart disease. The company offers personalized programs that adapt to the needs of participants, including services for diabetes prevention and management, hypertension, behavioral health, and musculoskeletal issues. By integrating professional health coaching, connected devices, real-time data, and personalized feedback, Omada Health strives to empower individuals to engage with their health and achieve sustainable lifestyle changes. It is recognized as the largest provider of the National Diabetes Prevention Program by the CDC.

Health Catalyst

Series C in 2014
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

iRhythm Technologies

Series D in 2013
iRhythm Technologies, Inc. is a digital healthcare company focused on improving the diagnosis and monitoring of cardiac arrhythmias in patients. Headquartered in San Francisco, the company provides innovative ambulatory electrocardiogram (ECG) monitoring solutions, primarily through its flagship product, the Zio service. This service utilizes a lightweight, wire-free, patch-based biosensor that patients can wear for up to 14 days, allowing for continuous heart monitoring. The Zio system integrates cloud-based data analytics and machine-learning capabilities to transform extensive heartbeat data into actionable clinical insights. By streamlining the diagnostic process, iRhythm aims to enhance patient health outcomes and reduce unnecessary healthcare expenses. Additionally, the company collaborates with Verily Life Sciences to develop advanced atrial fibrillation screening and monitoring products. Established in 2006, iRhythm continues to lead in the digital healthcare space by redefining cardiac arrhythmia diagnosis.

Health Catalyst

Series B in 2013
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

iRhythm Technologies

Private Equity Round in 2012
iRhythm Technologies, Inc. is a digital healthcare company focused on improving the diagnosis and monitoring of cardiac arrhythmias in patients. Headquartered in San Francisco, the company provides innovative ambulatory electrocardiogram (ECG) monitoring solutions, primarily through its flagship product, the Zio service. This service utilizes a lightweight, wire-free, patch-based biosensor that patients can wear for up to 14 days, allowing for continuous heart monitoring. The Zio system integrates cloud-based data analytics and machine-learning capabilities to transform extensive heartbeat data into actionable clinical insights. By streamlining the diagnostic process, iRhythm aims to enhance patient health outcomes and reduce unnecessary healthcare expenses. Additionally, the company collaborates with Verily Life Sciences to develop advanced atrial fibrillation screening and monitoring products. Established in 2006, iRhythm continues to lead in the digital healthcare space by redefining cardiac arrhythmia diagnosis.

Hemosphere

Series A in 2010
Hemosphere developed and markets the HeRO (Hemodialysis Reliable Outflow) Graft, a proprietary graft-based solution for end-stage renal disease (ESRD) hemodialysis patients with limited access options and central venous obstruction.

Free & Clear

Venture Round in 2010
Free & Clear, Inc. specializes in providing phone-based tobacco treatment services aimed at employers, health plans, and government agencies. The company offers a comprehensive tobacco cessation program, including Quit For Life, which assists employees and members in quitting smoking and using smokeless tobacco. Additionally, Free & Clear addresses broader health risks linked to chronic diseases through its Mind & Body Program, which focuses on behavior change and encourages individuals to maintain a healthy weight. By delivering these clinically proven interventions, Free & Clear aims to support a healthier workforce and reduce tobacco-related health issues.

Silverlink Communications

Series D in 2009
Silverlink Communications is a healthcare IT company that develops solutions for patient communications and engagement. The company provides communications services for managed care, pharmacy, population health, Medicare and Medicaid, multi-channel services, and interactive voice services.

Proteus Digital Health

Series B in 2004
Proteus Digital Health® is creating a new category of pharmaceuticals: Digital Medicines. Digital Medicines includes drugs that communicate when they’ve been taken, wearable sensors that capture physiologic response, applications that support patient self-care and physician decision making and data analytics to serve the needs of doctors and health systems. The goal of Digital Medicines is to empower patients and their families, enable physicians and health systems to more effectively manage risk and ensure that outcomes are reliably achieved.

The Center from Health Promotion

Venture Round in 2003
The Center for Health Promotion Inc. delivers tobacco cessation and weight management services to customers nationwide. As an operating unit of Group Health Cooperative (Seattle) for almost 20 years, CHP developed the telephone-based Free & Clear program and established itself a national leader in tobacco cessation. Today CHP continues to deliver tobacco cessation services through health plans, businesses and labor organizations around the country. CHP also provides phone-based tobacco cessation services to residents of Georgia, Maine, Minnesota, Oklahoma, Oregon, Utah, Washington and Wisconsin through contracts with state agencies or coalitions. The company is actively engaged in research trials with major research centers including The Stanford Research Institute in Menlo Park, Calif., the Center for Health Research in Portland, Ore., and the Fred Hutchison Cancer Research Center and Group Health's Center for Health Studies, both in Seattle. This active research is undertaken to help improve CHP's services to smokers and increase scientific understanding of this key health issue.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.